Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
[Disclosure] SK Square (402340) – Decision on Foreign Exchange Listing of Securities  / 2026-06-24

[Disclosure] SK Square (402340) – Decision on Foreign Exchange Listing of Securities / 2026-06-24

Semiconductors
[Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-06-24

[Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-06-24

Semiconductors
[Disclosure] SK Hynix (000660) – Decision on Listing Shares, etc. on Foreign Securities Market / 2026-06-24

[Disclosure] SK Hynix (000660) – Decision on Listing Shares, etc. on Foreign Securities Market / 2026-06-24

Disclosures
[Disclosure] Hanwha Systems (272210) – Decision to Acquire Tangible Assets (Land & Building) from Hanwha Corporation for KRW 287.85B

[Disclosure] Hanwha Systems (272210) – Decision to Acquire Tangible Assets (Land & Building) from Hanwha Corporation for KRW 287.85B

Disclosures
[Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-22

[Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-22

Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding  / 2026-06-22

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-06-22

Semiconductors
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-06-19

[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-06-19

Disclosures
[Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Ulcerative Colitis) / 2026-06-18

[Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Ulcerative Colitis) / 2026-06-18

Bio & Healthcare
[Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Crohn’s Disease) / 2026-06-18

[Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Crohn’s Disease) / 2026-06-18

Disclosures
[Disclosure] Hyundai Motor (005380) – Notice of Holding Investor Relations (IR) Event for Institutional Investors

[Disclosure] Hyundai Motor (005380) – Notice of Holding Investor Relations (IR) Event for Institutional Investors

Disclosures

Posts pagination

Previous 1 … 13 14 15 … 224 Next

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme